SOLUTIONSRX

Serial Number 90791011
Registration 7307670
700

Registration Progress

Application Filed
Jun 23, 2021
Under Examination
Approved for Publication
Dec 5, 2023
Published for Opposition
Dec 5, 2023
Registered
Feb 20, 2024

Trademark Image

SOLUTIONSRX

Basic Information

Serial Number
90791011
Registration Number
7307670
Filing Date
June 23, 2021
Registration Date
February 20, 2024
Published for Opposition
December 5, 2023
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
Feb 20, 2024
Registration
Registered
Classes
005

Rights Holder

Pharmacy and Healthcare Solutions, LLC

16
Address
223 Fulton Street
Iuka, MS 38852

Ownership History

Pharmacy and Healthcare Solutions, LLC

Original Applicant
16
Iuka, MS

Pharmacy and Healthcare Solutions, LLC

Owner at Publication
16
Iuka, MS

Pharmacy and Healthcare Solutions, LLC

Original Registrant
16
Iuka, MS

Legal Representation

Attorney
Otis R. Tims

USPTO Deadlines

Next Deadline
1514 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20240220)
Due Date
February 20, 2030
Grace Period Ends
August 20, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

35 events
Date Code Type Description Documents
Feb 20, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Feb 20, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Dec 5, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Dec 5, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Nov 15, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Nov 1, 2023 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 30, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Sep 29, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Sep 29, 2023 ERFR I TEAS REQUEST FOR RECONSIDERATION RECEIVED Loading...
Jul 7, 2023 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Jul 7, 2023 GNFR O FINAL REFUSAL E-MAILED Loading...
Jul 7, 2023 CNFR R FINAL REFUSAL WRITTEN Loading...
Jun 5, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jun 5, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jun 5, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Mar 7, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Mar 7, 2023 GNRT O NON-FINAL ACTION E-MAILED Loading...
Mar 7, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Feb 4, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Feb 4, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Feb 3, 2023 ALIE A ASSIGNED TO LIE Loading...
Dec 5, 2022 NREV E NOTICE OF REVIVAL - E-MAILED Loading...
Dec 4, 2022 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Dec 4, 2022 PETG O PETITION TO REVIVE-GRANTED Loading...
Dec 4, 2022 PROA I TEAS PETITION TO REVIVE RECEIVED Loading...
Oct 5, 2022 MAB2 E ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND Loading...
Oct 4, 2022 MAB2 O ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND Loading...
Oct 4, 2022 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Loading...
Mar 15, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Mar 15, 2022 GNRT F NON-FINAL ACTION E-MAILED Loading...
Mar 15, 2022 CNRT R NON-FINAL ACTION WRITTEN Loading...
Mar 14, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 9, 2021 MDSM E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Sep 8, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jun 26, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Dietary and nutritional supplements
First Use Anywhere: Apr 1, 2021
First Use in Commerce: Apr 1, 2021

Additional Information

Design Mark
The mark consists of letters forming the word "SOLUTIONSRx" in stylized text above a stylized representation of a medicine capsule divided from top to bottom.
Pseudo Mark
SOLUTIONS RX

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"SOLUTIONSRX"